Evidence map›Paper›PMID 39858878›Full record

ArticleMicroorganisms2025

Mycobacteria Exploit Host GPR84 to Dampen Pro-Inflammatory Responses and Promote Infection in Macrophages.

Reziya Wumaier, Ke Zhang, Jing Zhou, Zilu Wen, Zihan Chen, Geyang Luo, Hao Wang, Juliang Qin, Bing Du, Hua Ren and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Reziya WumaierKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Shanghai Public Health Clinical Center, Fudan University, Shanghai 200433, China.ORCID 0000-0002-7331-6212
Ke ZhangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Jing ZhouShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Zilu WenShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Zihan ChenShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Geyang LuoShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Hao WangShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Juliang QinShanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.
Bing DuShanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.
Hua RenShanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.ORCID 0000-0002-8809-7972
Yanzheng SongShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Qian GaoKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Shanghai Public Health Clinical Center, Fudan University, Shanghai 200433, China.
Bo YanShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.ORCID 0000-0002-7308-8942

Funding

National Key Research and Development Program 2023YFE0199200National Natural Science Foundation of China 32470186National Natural Science Foundation of China 82272376National Natural Science Foundation of China 82372263Science and Technology Commission of Shanghai Municipality 23141901800Science and Technology Commission of Shanghai Municipality 23141903300Shanghai Municipal Science and Technology Major Project ZD2021CY001
6 · The paper itself

Abstract

Tuberculosis (TB) remains the major cause of mortality and morbidity, causing approximately 1.3 million deaths annually. As a highly successful pathogen,

Indexed as

G-protein-coupled receptors 84 (GPR84)pro-inflammatory cytokinestuberculosis (TB)

Identifiers

PMID39858878
PMCPMC11767743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.